We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+5.24%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+1,389.53%
AUM
$463B
AUM Growth
+$17.5B
Cap. Flow
-$1.61B
Cap. Flow %
-0.35%
Top 10 Hldgs %
12.49%
Holding
2,596
New
97
Increased
1,091
Reduced
793
Closed
67

Top Buys

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$1.3B
2
AAL icon
American Airlines Group
AAL
+$853M
3
ISRG icon
Intuitive Surgical
ISRG
+$816M
4
MS icon
Morgan Stanley
MS
+$681M
5
WYNN icon
Wynn Resorts
WYNN
+$622M

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$1.4B
2
EBAY icon
eBay
EBAY
+$763M
3
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$760M
4
AVGO icon
Broadcom
AVGO
+$757M
5
USB icon
US Bancorp
USB
+$686M

Sector Composition

Rank Sector Weight
1 Healthcare 16.95%
2 Consumer Discretionary 13.63%
3 Financials 12.8%
4 Industrials 12.27%
5 Technology 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALR
1651
DELISTED
Alere Inc
ALR
$1.3M ﹤0.01%
34,740
-2,600
-7% -$92.6K
HOUS
1652
DELISTED
Anywhere Real Estate
HOUS
$1.29M ﹤0.01%
34,313
-1,384
-4% -$53.7K
HAIN icon
1653
Hain Celestial
HAIN
$52.8M
$1.29M ﹤0.01%
29,000
+1,800
+7% +$80.2K
ACM icon
1654
Aecom
ACM
$8.11B
$1.28M ﹤0.01%
39,800
+5,500
+16% +$178K
CVA
1655
DELISTED
Covanta Holding Corporation
CVA
$1.28M ﹤0.01%
62,204
+15,000
+32% +$284K
KMT icon
1656
Kennametal
KMT
$2.38B
$1.27M ﹤0.01%
27,500
+4,300
+19% +$199K
AMCX icon
1657
AMC Global Media
AMCX
$505M
$1.27M ﹤0.01%
20,615
– –
ARRS
1658
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$1.27M ﹤0.01%
38,914
+3,700
+11% +$109K
URS
1659
DELISTED
URS CORP
URS
$1.26M ﹤0.01%
27,500
+6,800
+33% +$314K
HII icon
1660
Huntington Ingalls Industries
HII
$12.9B
$1.25M ﹤0.01%
13,270
+970
+8% +$96.9K
AFG icon
1661
American Financial Group
AFG
$12.1B
$1.25M ﹤0.01%
21,060
– –
ORIT
1662
DELISTED
Oritani Financial Corp. New
ORIT
$1.25M ﹤0.01%
81,400
– –
CFR icon
1663
Cullen/Frost Bankers
CFR
$10.6B
$1.25M ﹤0.01%
15,750
-2,200
-12% -$169K
THO icon
1664
Thor Industries
THO
$4.1B
$1.25M ﹤0.01%
22,000
– –
ORI icon
1665
Old Republic International
ORI
$10.4B
$1.25M ﹤0.01%
75,472
+1,259
+2% +$21K
OHI icon
1666
Omega Healthcare
OHI
$14.1B
$1.22M ﹤0.01%
33,150
+2,100
+7% +$74.9K
HASI icon
1667
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.42B
$1.22M ﹤0.01%
85,000
-7,580
-8% -$105K
DAR icon
1668
Darling Ingredients
DAR
$10.5B
$1.21M ﹤0.01%
58,000
+5,600
+11% +$113K
OMED
1669
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$1.21M ﹤0.01%
+52,036
New +$1.28M
TBNK
1670
DELISTED
Territorial Bancorp Inc.
TBNK
$1.21M ﹤0.01%
57,900
– –
AWH
1671
DELISTED
Allied World Assurance Co Hld Lt
AWH
$1.21M ﹤0.01%
31,800
– –
LXK
1672
DELISTED
Lexmark Intl Inc
LXK
$1.21M ﹤0.01%
25,100
– –
VOYA icon
1673
Voya Financial
VOYA
$9.18B
$1.2M ﹤0.01%
33,100
+6,600
+25% +$236K
FMI
1674
DELISTED
Foundation Medicine, Inc.
FMI
$1.2M ﹤0.01%
+44,413
New +$1.13M
KOG
1675
DELISTED
KODIAK OIL & GAS CORP
KOG
$1.2M ﹤0.01%
82,242
+1,042
+1% +$13.5K
65 66
67
68 69

Similar funds

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates's Q2 2014 Portfolio in Review

As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
  • T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
  • T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
  • T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
  • T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
  • T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
  • T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.

Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.